Transdermal drug delivery devices

Systems and devices for the transdermal delivery of the compound (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, 0-[3(3-methoxyphenyl)-2-propynyl]oxime are disclosed. These devices include a drug in adhesive reservoir layer and a skin contacting adhesive layer in which the skin contacting adhesive layer ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	DREYER, STEVE J
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Systems and devices for the transdermal delivery of the compound (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, 0-[3(3-methoxyphenyl)-2-propynyl]oxime are disclosed. These devices include a drug in adhesive reservoir layer and a skin contacting adhesive layer in which the skin contacting adhesive layer acts as a rate controlling membrane. These devices also include a drug in adhesive reservoir layer and a skin contacting adhesive, where a membrane is placed between the two adhesive layers. The compound is a muscarinic agonist, useful in the treatment of a variety of cognitive disorders, including Alzheimer's Disease.